Robert Toto, MD
Enriched profileMary M. Conroy Professor of Kidney Disease, Department of Internal Medicine; Distinguished Teaching Professor; Associate Dean of Clinical and Translational Research, Graduate School of Biomedical Sciences · The University of Texas Southwestern Medical Center
Robert Toto is Mary M. Conroy Professor of Kidney Disease, Department of Internal Medicine; Distinguished Teaching Professor; Associate Dean of Clinical and Translational Research, Graduate School of Biomedical Sciences at The University of Texas Southwestern Medical Center. OpenAlex indexes 390 publications with 33,663 citations (h-index 81); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Nephrology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Robert Toto, MD, is Mary M. Conroy Professor of Kidney Disease, Department of Internal Medicine at The University of Texas Southwestern Medical Center. The public record shows 390 publications with 33,663 citations (h-index 81), centered on Chronic Kidney Disease and Diabetes, Diabetes Treatment and Management, Blood Pressure and Hypertension Studies. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 14 companies, 22 NIH-funded awards (1986–2026).
- Most recent indexed publication: 2026 · Kidney360
- Top research focus: Chronic Kidney Disease and Diabetes
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 18 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 222.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- Effect of SGLT2i on Cardiovascular Biomarkers in Patients With Type 2 Diabetes and CKD Stage 3b-4
Sponsor: University of Texas Southwestern Medical Center
- Kidney Precision Medicine Project
Sponsor: Icahn School of Medicine at Mount Sinai
- Improving Chronic Disease Management With Pieces
Sponsor: University of Texas Southwestern Medical Center
Industry payments
Updated 27 Aug 2026
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca UK LimitedProgram year20254 payments
- Alnylam Pharmaceuticals Inc.Program year20253 payments
- Amgen Inc.Program year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
70.4%Angiotensin receptor blocker (ARB)31.8%Losartan Potassium60%Telmisartan40%Part D<11 patientsLoop diuretic12.8%Torsemide100%Part D≥12 patientsMetabolism & gastrointestinal
29.6%SGLT2 inhibitor15.6%Farxiga100%Part D<11 patientsVitamin D3 Analog7.8%Calcitriol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
22 NIH research awards on record, funded 1986–2026 per NIH RePORTER. The latest:
- Kidney Precision Medicine Project - Patient Engagement
Ut Southwestern Medical Center
FY2026$446,370U01DK133091 - UT Southwestern Center for Translational Medicine
Ut Southwestern Medical Center
FY2025$7,513,496UL1TR003163 - Kidney Precision Medicine Project - Patient Engagement
Ut Southwestern Medical Center
FY2025$396,371U01DK133091
Congress activity
Updated 27 Aug 2026
6 congress contributions (2019–2022) across ADA, ENDO per OpenAlex. The most recent:
- 866-P: Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis from the DAPA-CKD Study
ADA Scientific Sessions
ADA2022Co-authorPoster - 130-LB: Dapagliflozin and the Incidence of Type 2 Diabetes in Patients with Chronic Kidney Disease
ADA Scientific Sessions
ADA2021Co-authorLate-breaking - 317-OR: Efficacy and Safety of Dapagliflozin by Glycemic Status in the DAPA-CKD Trial
ADA Scientific Sessions
ADA2021Co-authorOral
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- A Hierarchical Composite Endpoint for Chronic Kidney Disease Progression in Patients with Focal Segmental Glomerulosclerosis.
Clinical journal of the American Society of Nephrology
Article2026 - Effects of Dapagliflozin on Health-Related Quality of Life in Patients with CKD.
Journal of the American Society of Nephrology
Article2026 - Effects of Dapagliflozin on Progression of CKD According to Different Rates of Pretrial eGFR Loss.
Clinical journal of the American Society of Nephrology
Article2025
Most-cited works
by citation count (OpenAlex)- 01Resistant Hypertension: Diagnosis, Evaluation, and Treatment2,238 citations2008
- 02A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease2,078 citations2009
- 03Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis1,877 citations2002
- 04
- 05Resistant Hypertension: Diagnosis, Evaluation, and Treatment1,408 citations2008
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/robert-toto-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
pmc.ncbi.nlm.nih.gov/articles/PMC9076781
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmc.ncbi.nlm.nih.gov ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
Editorial & leadership roles
journal and society appointments- Editorial board member
Kidney International
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →utswmed.org ↗ - Editorial board member
Journal of the American Society of Nephrology (JASN)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →utswmed.org ↗ - Editorial board member
American Journal of Kidney Disease and Nephrology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →utswmed.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- O'Donnell School of Public Health (formerly Dept of Public Health)
UT Southwestern -- secondary departmental appointment
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utsouthwestern.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Margaret Pearle, MD, PhD
The University of Texas Southwestern Medical Center
George Buchanan, MD
The University of Texas Southwestern Medical Center
Vitaly Margulis, MD
The University of Texas Southwestern Medical Center
Susan Iannaccone, MD
The University of Texas Southwestern Medical Center